Novavax
NVAX
#4816
Rank
NZ$3.74 B
Marketcap
NZ$22.72
Share price
15.80%
Change (1 day)
51.37%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -NZ$0.39 Billion

According to Novavax's latest financial reports the company's current earnings are NZ$0.41 Billion. In 2025 the company made an earning of NZ$0.82 Billion, an increase over its 2024 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.39 Billion-146.76%
2025 NZ$0.82 B-396.87%
2024 -NZ$0.28 Billion-70.39%
2023 -NZ$0.95 Billion-16.59%
2022 -NZ$1.13 Billion-62.58%
2021 -NZ$3.02 Billion320.54%
2020 -NZ$0.72 Billion234.22%
2019 -NZ$0.22 Billion-30.17%
2018 -NZ$0.31 Billion1.69%
2017 -NZ$0.31 Billion-36.44%
2016 -NZ$0.48 Billion70.4%
2015 -NZ$0.28 Billion89.27%
2014 -NZ$0.15 Billion59.83%
2013 -NZ$92.31 Million81.9%
2012 -NZ$50.75 Million50.33%
2011 -NZ$33.76 Million
2009 -NZ$66.62 Million8.8%
2008 -NZ$61.23 Million18.01%
2007 -NZ$51.89 Million18.33%
2006 -NZ$43.85 Million168.31%
2005 -NZ$16.35 Million-62.51%
2004 -NZ$43.6 Million52.4%
2003 -NZ$28.61 Million-28.21%
2002 -NZ$39.85 Million
2000 -NZ$22.71 Million177%
1999 -NZ$8.2 Million-11.54%
1998 -NZ$9.27 Million10.64%
1997 -NZ$8.38 Million-9.62%
1996 -NZ$9.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.65 B-7,047.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.30 B-3,191.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.53 B-6,514.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$14.05 B-3,631.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-NZ$0.24 Billion-41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.59 Billion 45.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.26 B-167.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$14.42 Million-96.38%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.68 Billion 70.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.17 Billion-57.43%๐Ÿ‡บ๐Ÿ‡ธ USA